Chemical Structure : TAS0612
CAS No.: 2148902-58-1
货号: PC-38198Not For Human Use, Lab Use Only.
TAS0612 (TAS-0612) is an orally bioavailable multikinase inhibitor of AKT, p70S6K, and p90RSK, inhibits Y-box-binding protein (YBX1) phosphorylation.
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
TAS0612 (TAS-0612) is an orally bioavailable multikinase inhibitor of AKT, p70S6K, and p90RSK, inhibits Y-box-binding protein (YBX1) phosphorylation.
TAS0612 inhibits cell proliferation and suppresses the phosphorylation of YBX1 in TNBC cell lines, shows antitumor effect against antiestrogen-resistant cells and TNBC cells in vivo.
TAS0612 inhibited pYBX1, pPRAS40 and pS6 in ERα(+)/HER2(−) and ERα(−)/HER2(+) cell lines, the expression levels of pAKT, pp90RSK, and pp70S6K were increased following treatment with relatively higher doses of TAS0612.
TAS0612 showed potent antitumor effects and marked inhibition of pYBX1 and pS6 in the experimental therapeutic model of TNBC.
分子量 | 573.61 | |
分子式 | C27H34F3N9O2 | |
外观性状 | Solid | |
储存条件 |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
4-(4-(3-((2-(tert-butylamino)ethyl)amino)-6-(5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl)pyridin-2-yl)piperidin-1-yl)-5,5-dimethyl-5,7-dihydro-6H-pyrrolo[2,3-d]pyrimidin-6-one |
1. Shibata T, et al. Mol Cancer Ther. 2020 Mar;19(3):882-894.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright